BETA HCG AS TUMOR-MARKER IN TROPHOBLASTIC DISEASES

被引：0
|
作者：
TSCHERNE, G
机构：
来源：
ARCHIVES OF GYNECOLOGY AND OBSTETRICS | 1991年 / 250卷 / 1-4期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：90 / 91
页数：2
相关论文
共 50 条
  • [41] MAIN TOPICS OF TUMOR-MARKER
    HATTORI, N
    JAPANESE JOURNAL OF MEDICINE, 1988, 27 (01) : 96 - 98
  • [42] DEFINITION OF THE IDEAL TUMOR-MARKER
    COONER, WH
    UROLOGIC CLINICS OF NORTH AMERICA, 1993, 20 (04) : 575 - 579
  • [43] REIMBURSEMENT OF TUMOR-MARKER TESTS
    LOGUE, LJ
    CLINICAL CHEMISTRY, 1993, 39 (11B) : 2435 - 2438
  • [44] SERUM SP1, hPL AND BETA-hCG LEVELS IN TROPHOBLASTIC DISEASES
    张为远
    闫国来
    中华医学杂志(英文版), 1991, (12) : 995 - 998
  • [45] EXPERIENCE OF THE OXFORD TUMOR-MARKER
    KRAUSZ, TJ
    VANNOORDEN, S
    EVANS, DJ
    LANCET, 1983, 1 (8333): : 1097 - 1097
  • [46] HCG tests in the management of gestational trophoblastic diseases
    Cole, LA
    Sutton, JM
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2003, 46 (03): : 523 - 540
  • [47] PLASMINOGEN-ACTIVATOR INHIBITOR-2 (PAI 2) - NO TUMOR-MARKER IN BETA-HCG- POSITIVE TESTICULAR CANCER AND MALIGNANT HISTOCYTOMA
    SALAT, C
    CLEMM, C
    REINHARDT, B
    HILLER, E
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1274 - 1274
  • [48] SERUM BETA-2-MICROGLOBULIN A TUMOR-MARKER IN MALIGNANT-LYMPHOMAS
    AULBERT, E
    STEFFENS, O
    MEDIZINISCHE KLINIK, 1990, 85 (01) : 13 - 17
  • [49] EVALUATION OF A NEW TUMOR-MARKER - SCC
    MOLINA, R
    BALLESTA, AM
    FILELLA, X
    SANTABARBARA, P
    BORRAS, G
    BALAGUE, A
    TUMOR BIOLOGY, 1987, 8 (06) : 327 - 327
  • [50] P53 AS A TUMOR-MARKER
    COUGOIRE, J
    CANCER JOURNAL - FRANCE, 1991, 4 (05): : 299 - 299
12345